Advisory Services Network’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Advisory Services Network’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-500	Closed	-$1.52K	–	3822
2023 Q4	$1.52K	Buy	+500	New	+$940	﹤0.01%	3458
2023 Q2	–	Sell	-200	Closed	-$536	–	3820
2023 Q1	$536	Hold	200	–	–	﹤0.01%	3732
2022 Q4	$1.09K	Buy	+200	New	+$1.68K	﹤0.01%	3574
2021 Q3	–	Sell	-725	Closed	-$16K	–	3364
2021 Q2	$16K	Buy	+725	New	+$16.1K	﹤0.01%	2611
2021 Q1	–	Sell	-725	Closed	-$13K	–	3059
2020 Q4	$13K	Sell	725 -1,500	-67%	-$22.4K	﹤0.01%	2324
2020 Q3	$26K	Buy	+2,225	New	+$36.7K	﹤0.01%	1953

Other funds holding GTHX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Advisory Services Network's GTHX Position: Q1 2024 in Review

Advisory Services Network sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2024, closing a stake of 500 shares — an estimated $1.52K sold.

Advisory Services Network first reported a position in GTHX in Q3 2020 and held it in 6 quarters. The position peaked at $26K in Q3 2020. 86 funds tracked by Wall St. Rank hold GTHX as of Q1 2024.

Advisory Services Network reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Advisory Services Network sold 500 G1 Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.52K.
Advisory Services Network first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
Advisory Services Network's G1 Therapeutics, Inc. Common Stock position peaked at $26K in Q3 2020.
86 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.